Table 1.
Patient cohort characteristics.
| PsA n = 17 | AS n = 35 | Combined n = 52 | |
|---|---|---|---|
| Male sex, n (%) | 12 (71%) | 29 (83%) | 41 (79%) |
| Age, years, mean ± sd | 37.43 ± 8.77 | 33.85 ± 7.6 | 34.90 ± 8.03 |
| Disease duration, years, mean ± sd | 8.4 ± 6.11 | 12.9 ± 8.15 | 11.3 ± 7.7 |
| HLA-B*27+ donors, n (%) * | 7 (41%) | 30 (86%) | 37 (71%) |
| HLA-B*38+ donors, n (%) * | 7 (41%) | 8 (23%) | 15 (29%) |
| HLA-B*27+/B38+ donors, n (%) | 0 | 5 (14%) | 5 (10%) |
*Including HLA-B*27+/B*38+ donors.
PsA, psoriatic arthritis; AS, ankylosing spondylitis; HLA, human leukocyte antigen; sd, standard deviation.